Acatavir

0/10Traction

The startup develops a targeted therapy for Upper Respiratory Tract Inflammation Disease (URTD) in cats, specifically addressing feline rhinitis caused by feline herpesvirus (FHV-1) and feline calicivirus (FCV). This treatment offers pet owners an effective solution for managing and preventing the symptoms associated with cat flu.

Poland · HQ

Founded 2020

Biotechnology
Pet Technology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup develops a targeted therapy for Upper Respiratory Tract Inflammation Disease (URTD) in cats, specifically addressing feline rhinitis caused by feline herpesvirus (FHV-1) and feline calicivirus (FCV). This treatment offers pet owners an effective solution for managing and preventing the symptoms associated with cat flu.